(Rhone Poulenc Pharma Inc) plan spend 29 mln dlrs five research development Canada. It investment depends passage federal government bill proposes great protection holder drug patents. The company spend 7.9 mln dlrs upgrade Montreal operations. It patent law drug company reasonable protection generic drug copying compounds. Reuter 